TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2516459
log Bayes Factor = 101.897
Chromosome 6   position 31,419,042  (GRCh37) Explore rs2516459 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E03.9 Hypothyroidism, unspecified
0.000 0.000 1.000
E05.9 Thyrotoxicosis, unspecified
0.000 0.000 1.000
K90.0 Coeliac disease
0.000 0.000 1.000
M45.X9 Ankylosing spondylitis (Site unspecified)
0.000 0.000 1.000
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.000 1.000
E03 Other hypothyroidism
0.000 0.000 1.000
E00-E07 Disorders of thyroid gland
0.000 0.000 1.000
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.002 0.998
M45 Ankylosing spondylitis
0.000 0.005 0.995
M45.X0 Ankylosing spondylitis (Multiple sites in spine)
0.000 0.010 0.990
E07 Other disorders of thyroid
0.000 0.070 0.930
M45.X2 Ankylosing spondylitis (Cervical region)
0.000 0.072 0.928
E83.1 Disorders of iron metabolism
0.920 0.080 0.000
E07.9 Disorder of thyroid, unspecified
0.000 0.113 0.887
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.000 0.113 0.887
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.000 0.114 0.886
E06 Thyroiditis
0.000 0.114 0.886
C85.1 B-cell lymphoma, unspecified
0.000 0.118 0.882
E03.8 Other specified hypothyroidism
0.000 0.122 0.878
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.000 0.144 0.856
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.000 0.150 0.850
C83.3 Large cell (diffuse)
0.000 0.154 0.846
C83 Diffuse non-Hodgkin's lymphoma
0.000 0.158 0.842
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.000 0.171 0.829
J45.9 Asthma, unspecified
0.000 0.196 0.804
E06.3 Autoimmune thyroiditis
0.000 0.225 0.775
M45.X6 Ankylosing spondylitis (Lumbar region)
0.000 0.231 0.769
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.277 0.723
E05.5 Thyroid crisis or storm
0.000 0.283 0.717
E05.4 Thyrotoxicosis factitia
0.000 0.283 0.717
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.283 0.717
E03.5 Myxoedema coma
0.000 0.283 0.717
E03.4 Atrophy of thyroid (acquired)
0.000 0.283 0.717
E03.3 Postinfectious hypothyroidism
0.000 0.283 0.717
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.283 0.717
E00 Congenital iodine-deficiency syndrome
0.000 0.283 0.717
E05.8 Other thyrotoxicosis
0.000 0.285 0.714
M45.X8 Ankylosing spondylitis (Sacral and sacrococcygeal region)
0.000 0.286 0.713
M45.X7 Ankylosing spondylitis (Lumbosacral region)
0.000 0.286 0.713
M45.X5 Ankylosing spondylitis (Thoracolumbar region)
0.000 0.286 0.713
M45.X4 Ankylosing spondylitis (Thoracic region)
0.000 0.286 0.713
M45.X3 Ankylosing spondylitis (Cervicothoracic region)
0.000 0.286 0.713
M45.X1 Ankylosing spondylitis (Occipito-atlanto-axial region)
0.000 0.286 0.713
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.287 0.712
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.000 0.299 0.701
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.301 0.699
C82.3 Follicular lymphoma grade IIIa
0.000 0.302 0.698
C82.2 Large cell, follicular
0.000 0.325 0.675
E06.9 Thyroiditis, unspecified
0.000 0.331 0.669
E07.1 Dyshormogenetic goitre
0.000 0.333 0.667
E07.0 Hypersecretion of calcitonin
0.000 0.333 0.667
C82.0 Small cleaved cell, follicular
0.000 0.335 0.665
E03.1 Congenital hypothyroidism without goitre
0.000 0.335 0.665
E06.5 Other chronic thyroiditis
0.000 0.337 0.663
C82.4 Follicular lymphoma grade IIIb
0.000 0.337 0.662
C83.7 Burkitt's tumour
0.000 0.338 0.662
C81 Hodgkin's disease
0.000 0.351 0.649
C86 Other specified types of T/NK-cell lymphoma
0.000 0.351 0.649
E06.1 Subacute thyroiditis
0.000 0.351 0.648
C84 Peripheral and cutaneous T-cell lymphomas
0.000 0.352 0.648
C85.0 Lymphosarcoma
0.000 0.364 0.636
E06.4 Drug-induced thyroiditis
0.000 0.364 0.635
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.364 0.635
E06.0 Acute thyroiditis
0.000 0.364 0.635
E07.8 Other specified disorders of thyroid
0.000 0.373 0.627
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.000 0.380 0.620
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.386 0.614
C88 Malignant immunoproliferative diseases
0.000 0.390 0.610
C82.6 Cutaneous follicle centre lymphoma
0.000 0.390 0.610
C82.5 Diffuse follicle centre lymphoma
0.000 0.390 0.610
C83.6 Undifferentiated (diffuse)
0.000 0.396 0.603
C83.5 Lymphoblastic (diffuse)
0.000 0.396 0.603
C83.4 Immunoblastic (diffuse)
0.000 0.396 0.603
C83.2 Mixed small and large cell (diffuse)
0.000 0.396 0.603
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.399 0.600
C81.9 Hodgkin's disease, unspecified
0.000 0.439 0.561
C94 Other leukaemias of specified cell type
0.000 0.439 0.561
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.000 0.449 0.551
C95 Leukaemia of unspecified cell type
0.000 0.452 0.548
C82.1 Mixed small cleaved and large cell, follicular
0.000 0.459 0.541
C83.1 Small cleaved cell (diffuse)
0.000 0.467 0.533
C84.8 Cutaneous T-cell lymphoma, unspecified
0.000 0.480 0.520
C93 Monocytic leukaemia
0.000 0.481 0.518
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.486 0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.486 0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.486 0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.486 0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.486 0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.486 0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.486 0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.486 0.514
C86.5 Angioimmunoblastic T-cell lymphoma
0.000 0.500 0.500
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.000 0.504 0.496
C81.2 Mixed cellularity
0.000 0.505 0.495
C84.5 Other and unspecified T-cell lymphomas
0.000 0.515 0.485
C84.0 Mycosis fungoides
0.000 0.520 0.479
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.000 0.534 0.465
C81.3 Lymphocytic depletion
0.000 0.534 0.465
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.000 0.535 0.465
C86.4 Blastic NK-cell lymphoma
0.000 0.535 0.465
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.000 0.535 0.465
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.000 0.535 0.465
C86.1 Hepatosplenic T-cell lymphoma
0.000 0.535 0.465
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.000 0.535 0.465
C84.9 Mature T/NK-cell lymphoma, unspecified
0.000 0.535 0.465
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.000 0.535 0.465
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.000 0.535 0.465
C84.3 Lymphoepithelioid lymphoma
0.000 0.535 0.465
C84.2 T-zone lymphoma
0.000 0.535 0.465
C84.1 Sezary's diease
0.000 0.535 0.465
C81.7 Other Hodgkin's disease
0.000 0.548 0.452
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.000 0.560 0.440
C96.8 Histiocytic sarcoma
0.000 0.560 0.440
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.560 0.440
C96.6 Unifocal Langerhans-cell histiocytosis
0.000 0.560 0.440
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.000 0.560 0.440
C96.4 Sarcoma of dendritic cells (accessory cells)
0.000 0.560 0.440
C96.3 True histiocytic lymphoma
0.000 0.560 0.440
C96.2 Malignant mast cell tumour
0.000 0.560 0.440
C96.1 Malignant histiocytosis
0.000 0.560 0.440
C96.0 Letterer-Siwe disease
0.000 0.560 0.440
C88.9 Malignant immunoproliferative disease, unspecified
0.000 0.563 0.437
C88.7 Other malignant immunoproliferative diseases
0.000 0.563 0.437
C88.3 Immunoproliferative small intestinal disease
0.000 0.563 0.437
C88.2 Gamma heavy chain disease
0.000 0.563 0.437
C88.1 Alpha heavy chain disease
0.000 0.563 0.437
C85.7 Other specified types of non-Hodgkin's lymphoma
0.000 0.568 0.432
C95.9 Leukaemia, unspecified
0.000 0.576 0.423
C91 Lymphoid leukaemia
0.000 0.578 0.422
C81.1 Nodular sclerosis
0.000 0.591 0.409
C94.7 Other specified leukaemias
0.000 0.597 0.402
C94.5 Acute myelofibrosis
0.000 0.597 0.402
C94.4 Acute panmyelosis
0.000 0.597 0.402
C94.3 Mast cell leukaemia
0.000 0.597 0.402
C94.2 Acute megakaryoblastic leukaemia
0.000 0.597 0.402
C94.1 Chronic erythraemia
0.000 0.597 0.402
C94.0 Acute erythraemia and erythroleukaemia
0.000 0.597 0.402
C95.7 Other leukaemia of unspecified cell type
0.000 0.607 0.393
C95.2 Subacute leukaemia of unspecified cell type
0.000 0.607 0.393
K90 Intestinal malabsorption
0.000 0.610 0.390
C84.4 Peripheral T-cell lymphoma
0.000 0.612 0.388
C81.0 Lymphocytic predominance
0.000 0.613 0.387
C93.9 Monocytic leukaemia, unspecified
0.000 0.628 0.372
C93.7 Other monocytic leukaemia
0.000 0.628 0.372
C93.3 Juvenile myelomonocytic leukaemia
0.000 0.628 0.372
C93.2 Subacute monocytic leukaemia
0.000 0.628 0.372
C93.0 Acute monocytic leukaemia
0.000 0.628 0.372
C95.1 Chronic leukaemia of unspecified cell type
0.000 0.634 0.365
C91.9 Lymphoid leukaemia, unspecified
0.000 0.647 0.353
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.000 0.650 0.349
C88.0 Waldenstrom's macroglobulinaemia
0.000 0.657 0.342
C91.5 Adult T-cell leukaemia
0.000 0.666 0.334
C92 Myeloid leukaemia
0.000 0.670 0.330
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.001 0.683 0.316
C95.0 Acute leukaemia of unspecified cell type
0.000 0.684 0.315
K90.9 Intestinal malabsorption, unspecified
0.000 0.688 0.312
C91.8 Mature B-cell leukaemia Burkitt-type
0.000 0.697 0.303
C91.7 Other lymphoid leukaemia
0.000 0.697 0.303
C91.6 Prolymphocytic leukaemia of T-cell type
0.000 0.697 0.303
C91.3 Prolymphocytic leukaemia
0.000 0.697 0.303
C91.2 Subacute lymphocytic leukaemia
0.000 0.697 0.303
K90.3 Pancreatic steatorrhoea
0.000 0.720 0.280
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.720 0.280
K90.1 Tropical sprue
0.000 0.720 0.280
C93.1 Chronic monocytic leukaemia
0.001 0.723 0.276
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.724 0.276
C92.1 Chronic myeloid leukaemia
0.000 0.724 0.276
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.001 0.732 0.267
C91.0 Acute lymphoblastic leukaemia
0.000 0.747 0.253
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.000 0.763 0.237
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.000 0.763 0.237
C92.3 Myeloid sarcoma
0.000 0.763 0.237
C92.2 Subacute myeloid leukaemia
0.000 0.763 0.237
C92.5 Acute myelomonocytic leukaemia
0.000 0.775 0.225
K90.8 Other intestinal malabsorption
0.000 0.788 0.211
C92.9 Myeloid leukaemia, unspecified
0.000 0.790 0.210
C92.7 Other myeloid leukaemia
0.000 0.794 0.206
C90 Multiple myeloma and malignant plasma cell neoplasms
0.001 0.797 0.202
C92.4 Acute promyelocytic leukaemia
0.000 0.809 0.190
C91.1 Chronic lymphocytic leukaemia
0.000 0.815 0.185
E04 Other non-toxic goitre
0.000 0.829 0.171
C91.4 Hairy-cell leukaemia
0.001 0.835 0.164
J45 Asthma
0.000 0.848 0.152
C90.1 Plasma cell leukaemia
0.001 0.856 0.144
C90.3 Solitary plasmacytoma
0.001 0.863 0.136
C83.0 Small cell (diffuse)
0.006 0.868 0.126
E04.8 Other specified non-toxic goitre
0.000 0.877 0.123
E10 Insulin-dependent diabetes mellitus
0.000 0.879 0.121
E10-E14 Diabetes mellitus
0.000 0.879 0.121
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.880 0.120
E10.9 Without complications
0.000 0.883 0.117
E14 Unspecified diabetes mellitus
0.000 0.885 0.115
E14.3 With ophthalmic complications
0.000 0.886 0.114
J45.1 Nonallergic asthma
0.000 0.890 0.110
E10.3 With ophthalmic complications
0.000 0.891 0.109
E83 Disorders of mineral metabolism
0.108 0.892 0.000
E10.2 With renal complications
0.000 0.893 0.107
J45.8 Mixed asthma
0.000 0.893 0.106
C92.0 Acute myeloid leukaemia
0.000 0.894 0.106
E10.1 With ketoacidosis
0.000 0.899 0.101
E04.9 Non-toxic goitre, unspecified
0.000 0.899 0.101
E04.0 Non-toxic diffuse goitre
0.000 0.903 0.097
E14.2 Withrenal complications
0.000 0.909 0.091
E14.8 With unspecified complications
0.000 0.911 0.088
E10.7 With multiple complications
0.000 0.912 0.088
E10.6 With other specified complications
0.000 0.912 0.088
E14.5 With peripheral circulatory complications
0.000 0.912 0.088
E10.8 With unspecified complications
0.000 0.913 0.087
E12 Malnutrition-related diabetes mellitus
0.000 0.913 0.087
E14.1 With ketoacidosis
0.000 0.914 0.086
E14.7 With multiple complications
0.000 0.917 0.083
E14.0 With coma
0.000 0.917 0.083
E83.9 Disorder of mineral metabolism, unspecified
0.082 0.917 0.000
E13 Other specified diabetes mellitus
0.000 0.918 0.082
E04.2 Non-toxic multinodular goitre
0.000 0.918 0.082
E14.6 With other specified complications
0.000 0.920 0.080
E14.4 With neurological complications
0.000 0.921 0.079
C90.2 Plasmacytoma, extramedullary
0.001 0.922 0.077
E83.8 Other disorders of mineral metabolism
0.077 0.922 0.000
E83.2 Disorders of zinc metabolism
0.077 0.922 0.000
E83.0 Disorders of copper metabolism
0.077 0.922 0.000
E83.3 Disorders of phosphorus metabolism
0.077 0.923 0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.923 0.077
E10.4 With neurological complications
0.000 0.925 0.075
E10.0 With coma
0.000 0.929 0.070
E10.5 With peripheral circulatory complications
0.000 0.930 0.070
E40-E46 Malnutrition
0.000 0.931 0.069
E12.9 Without complications
0.000 0.938 0.062
E12.8 With unspecified complications
0.000 0.938 0.062
E12.7 With multiple complications
0.000 0.938 0.062
E12.6 With other specified complications
0.000 0.938 0.062
E12.5 With peripheral circulatory complications
0.000 0.938 0.062
E12.4 With neurological complications
0.000 0.938 0.062
E12.3 With ophthalmic complications
0.000 0.938 0.062
E12.2 With renal complications
0.000 0.938 0.062
E12.1 With ketoacidosis
0.000 0.938 0.062
E12.0 With coma
0.000 0.938 0.062
G35 Multiple sclerosis
0.061 0.939 0.000
E13.3 With ophthalmic complications
0.000 0.940 0.060
E13.8 With unspecified complications
0.000 0.941 0.059
E13.7 With multiple complications
0.000 0.941 0.059
E13.6 With other specified complications
0.000 0.941 0.059
E13.5 With peripheral circulatory complications
0.000 0.941 0.059
E13.4 With neurological complications
0.000 0.941 0.059
E13.2 With renal complications
0.000 0.941 0.059
E13.1 With ketoacidosis
0.000 0.941 0.059
E13.0 With coma
0.000 0.941 0.059
E15 Nondiabetic hypoglycaemic coma
0.000 0.944 0.055
E13.9 Without complications
0.000 0.947 0.053
E50-E64 Other nutritional deficiencies
0.000 0.949 0.051
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.950 0.050
E45 Retarded development following protein-energy malnutrition
0.000 0.950 0.050
E43 Unspecified severe protein-energy malnutrition
0.000 0.950 0.050
E42 Marasmic kwashiorkor
0.000 0.950 0.050
E41 Nutritional marasmus
0.000 0.950 0.050
E40 Kwashiorkor
0.000 0.950 0.050
E16 Other disorders of pancreatic internal secretion
0.000 0.953 0.047
E58 Dietary calcium deficiency
0.000 0.958 0.042
E83.5 Disorders of calcium metabolism
0.040 0.960 0.000
E16.1 Other hypoglycaemia
0.000 0.961 0.039
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.963 0.037
E63 Other nutritional deficiencies
0.000 0.963 0.037
E50 Vitamin A deficiency
0.000 0.963 0.037
E60 Dietary zinc deficiency
0.000 0.963 0.037
E59 Dietary selenium deficiency
0.000 0.963 0.037
E52 Niacin deficiency [pellagra]
0.000 0.963 0.037
E51 Thiamine deficiency
0.000 0.964 0.036
E44.1 Mild protein-energy malnutrition
0.000 0.964 0.036
E44.0 Moderate protein-energy malnutrition
0.000 0.964 0.036
G35-G37 Demyelinating diseases of the central nervous system
0.036 0.964 0.000
E54 Ascorbic acid deficiency
0.000 0.965 0.035
E56 Other vitamin deficiencies
0.000 0.965 0.035
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.966 0.033
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.966 0.033
E16.4 Abnormal secretion of gastrin
0.000 0.966 0.033
E16.3 Increased secretion of glucagon
0.000 0.966 0.033
E20-E35 Disorders of other endocrine glands
0.000 0.966 0.034
F20.9 Schizophrenia, unspecified
0.033 0.967 0.000
E46 Unspecified protein-energy malnutrition
0.000 0.967 0.033
E61 Deficiency of other nutrient elements
0.000 0.968 0.032
M45-M49 Spondylopathies
0.000 0.968 0.032
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.969 0.031
G37 Other demyelinating diseases of central nervous system
0.031 0.969 0.000
E55 Vitamin D deficiency
0.000 0.969 0.031
E65-E68 Obesity and other hyperalimentation
0.000 0.970 0.030
G37.9 Demyelinating disease of central nervous system, unspecified
0.030 0.970 0.000
E29 Testicular dysfunction
0.000 0.971 0.029
E24 Cushing's syndrome
0.000 0.971 0.029
E28 Ovarian dysfunction
0.000 0.971 0.029
E14.9 Without complications
0.000 0.973 0.027
E50.9 Vitamin A deficiency, unspecified
0.000 0.973 0.026
E50.8 Other manifestations of vitamin A deficiency
0.000 0.973 0.026
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.973 0.026
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.973 0.026
E50.5 Vitamin A deficiency with night blindness
0.000 0.973 0.026
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.973 0.026
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.973 0.026
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.973 0.026
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.973 0.026
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.973 0.026
E63.9 Nutritional deficiency, unspecified
0.000 0.973 0.026
E63.8 Other specified nutritional deficiencies
0.000 0.973 0.026
E63.1 Imbalance of constituents of food intake
0.000 0.973 0.026
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.973 0.026
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.973 0.026
E64.8 Sequelae of other nutritional deficiencies
0.000 0.973 0.026
E64.3 Sequelae of rickets
0.000 0.973 0.026
E64.2 Sequelae of vitamin C deficiency
0.000 0.973 0.026
E64.1 Sequelae of vitamin A deficiency
0.000 0.973 0.026
E64.0 Sequelae of protein-energy malnutrition
0.000 0.973 0.026
E29.1 Testicular hypofunction
0.000 0.973 0.027
E51.9 Thiamine deficiency, unspecified
0.000 0.974 0.026
E51.8 Other manifestations of thiamine deficiency
0.000 0.974 0.026
E51.1 Beriberi
0.000 0.974 0.026
E51.2 Wernicke's encephalopathy
0.000 0.974 0.026
E04.1 Non-toxic single thyroid nodule
0.000 0.975 0.025
E56.9 Vitamin deficiency, unspecified
0.000 0.975 0.025
E56.8 Deficiency of other vitamins
0.000 0.975 0.025
E56.0 Deficiency of vitamin E
0.000 0.975 0.025
E25 Adrenogenital disorders
0.000 0.975 0.025
E61.2 Magnesium deficiency
0.000 0.975 0.024
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.976 0.024
E32 Diseases of thymus
0.000 0.976 0.024
E31 Polyglandular dysfunction
0.000 0.976 0.024
E30 Disorders of puberty, not elsewhere classified
0.000 0.976 0.024
G36 Other acute disseminated demyelination
0.024 0.976 0.000
E28.3 Primary ovarian failure
0.000 0.976 0.024
F20 Schizophrenia
0.024 0.976 0.000
G37.8 Other specified demyelinating diseases of central nervous system
0.024 0.976 0.000
E24.2 Drug-induced Cushing's syndrome
0.000 0.976 0.024
J45.0 Predominantly allergic asthma
0.000 0.976 0.024
E24.9 Cushing's syndrome, unspecified
0.000 0.976 0.024
E56.1 Deficiency of vitamin K
0.000 0.977 0.023
E61.9 Deficiency of nutrient element, unspecified
0.000 0.977 0.023
E61.8 Deficiency of other specified nutrient elements
0.000 0.977 0.023
E61.7 Deficiency of multiple nutrient elements
0.000 0.977 0.023
E61.6 Vanadium deficiency
0.000 0.977 0.023
E61.5 Molybdenum deficiency
0.000 0.977 0.023
E61.4 Chromium deficiency
0.000 0.977 0.023
E61.3 Manganese deficiency
0.000 0.977 0.023
E61.0 Copper deficiency
0.000 0.977 0.023
L40.9 Psoriasis, unspecified
0.023 0.977 0.000
G37.5 Concentric sclerosis [Balo]
0.023 0.977 0.000
G37.4 Subacute necrotising myelitis
0.023 0.977 0.000
G37.2 Central pontine myelinolysis
0.023 0.977 0.000
G37.1 Central demyelination of corpus callosum
0.023 0.977 0.000
G37.0 Diffuse sclerosis
0.023 0.977 0.000
E24.0 Pituitary-dependent Cushing's disease
0.000 0.977 0.023
E28.2 Polycystic ovarian syndrome
0.000 0.977 0.023
E55.0 Rickets, active
0.000 0.977 0.022
K90-K93 Other diseases of the digestive system
0.000 0.978 0.022
E67 Other hyperalimentation
0.000 0.978 0.022
E68 Sequelae of hyperalimentation
0.000 0.978 0.022
E23 Hypofunction and other disorders of pituitary gland
0.000 0.978 0.022
M49 Spondylopathies in diseases classified elsewhere
0.000 0.978 0.021
E29.9 Testicular dysfunction, unspecified
0.000 0.979 0.021
E29.8 Other testicular dysfunction
0.000 0.979 0.021
E29.0 Testicular hyperfunction
0.000 0.979 0.021
C90.0 Multiple myeloma
0.001 0.979 0.020
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.979 0.021
E24.3 Ectopic ACTH syndrome
0.000 0.979 0.021
E24.1 Nelson's syndrome
0.000 0.979 0.021
E28.9 Ovarian dysfunction, unspecified
0.000 0.979 0.021
E28.8 Other ovarian dysfunction
0.000 0.979 0.021
E28.1 Androgen excess
0.000 0.979 0.021
E28.0 Oestrogen excess
0.000 0.979 0.021
E26 Hyperaldosteronism
0.000 0.980 0.020
E53 Deficiency of other B group vitamins
0.000 0.980 0.020
E22 Hyperfunction of pituitary gland
0.000 0.980 0.020
E24.8 Other Cushing's syndrome
0.000 0.981 0.019
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.981 0.019
E23.2 Diabetes insipidus
0.000 0.981 0.019
E83.4 Disorders of magnesium metabolism
0.018 0.981 0.000
F20.5 Residual schizophrenia
0.018 0.982 0.000
E25.9 Adrenogenital disorder, unspecified
0.000 0.982 0.018
E25.8 Other adrenogenital disorders
0.000 0.982 0.018
F10-F19 Mental and behavioural disorders due to psychoactive substance use
0.018 0.982 0.000
E30.9 Disorder of puberty, unspecified
0.000 0.982 0.017
E30.8 Other disorders of puberty
0.000 0.982 0.017
E30.1 Precocious puberty
0.000 0.982 0.017
E30.0 Delayed puberty
0.000 0.982 0.017
E31.9 Polyglandular dysfunction, unspecified
0.000 0.982 0.017
E31.8 Other polyglandular dysfunction
0.000 0.982 0.017
E31.1 Polyglandular hyperfunction
0.000 0.982 0.017
E31.0 Autoimmune polyglandular failure
0.000 0.982 0.017
E32.9 Disease of thymus, unspecified
0.000 0.982 0.017
E32.8 Other diseases of thymus
0.000 0.982 0.017
E32.1 Abscess of thymus
0.000 0.982 0.017
E32.0 Persistent hyperplasia of thymus
0.000 0.982 0.017
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.982 0.017
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.982 0.017
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.982 0.017
G36.9 Acute disseminated demyelination, unspecified
0.017 0.982 0.000
G36.8 Other specified acute disseminated demyelination
0.017 0.982 0.000
G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst]
0.017 0.982 0.000
F20.8 Other schizophrenia
0.017 0.983 0.000
F20.6 Simple schizophrenia
0.017 0.983 0.000
F20.4 Postschizophrenic depression
0.017 0.983 0.000
F20.3 Undifferentiated schizophrenia
0.017 0.983 0.000
F20.2 Catatonic schizophrenia
0.017 0.983 0.000
F20.1 Hebephrenic schizophrenia
0.017 0.983 0.000
E20 Hypoparathyroidism
0.000 0.983 0.017
F20.0 Paranoid schizophrenia
0.017 0.983 0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.983 0.017
F17 Mental and behavioural disorders due to use of tobacco
0.017 0.983 0.000
F17.1 Harmful use
0.017 0.983 0.000
E55.9 Vitamin D deficiency, unspecified
0.000 0.983 0.017
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances
0.017 0.983 0.000
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system
0.016 0.984 0.000
K93 Disorders of other digestive organs in diseases classified elsewhere
0.000 0.984 0.016
F11 Mental and behavioural disorders due to use of opioids
0.016 0.984 0.000
E16.2 Hypoglycaemia, unspecified
0.000 0.984 0.016
E67.8 Other specified hyperalimentation
0.000 0.984 0.016
E67.3 Hypervitaminosis D
0.000 0.984 0.016
E67.2 Megavitamin-B6 syndrome
0.000 0.984 0.016
E67.1 Hypercarotenaemia
0.000 0.984 0.016
E67.0 Hypervitaminosis A
0.000 0.984 0.016
G36.0 Neuromyelitis optica [Devic]
0.016 0.984 0.000
E61.1 Iron deficiency
0.000 0.984 0.016
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.984 0.016
E23.1 Drug-induced hypopituitarism
0.000 0.984 0.016
F20-F29 Schizophrenia, schizotypal and delusional disorders
0.016 0.984 0.000
M49.8 Spondylopathy in other diseases classified elsewhere
0.000 0.984 0.016
M49.4 Neuropathic spondylopathy
0.000 0.984 0.016
M49.3 Spondylopathy in other infectious and parasitic diseases classified elsewhere
0.000 0.984 0.016
M49.2 Enterobacterial spondylitis
0.000 0.984 0.016
M49.1 Brucella spondylitis
0.000 0.984 0.016
M49.0 Tuberculosis of spine
0.000 0.984 0.016
E23.6 Other disorders of pituitary gland
0.000 0.985 0.015
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine
0.015 0.985 0.000
F12 Mental and behavioural disorders due to use of cannabinoids
0.015 0.985 0.000
E26.9 Hyperaldosteronism, unspecified
0.000 0.985 0.015
F11.2 Dependence syndrome
0.015 0.985 0.000
E26.8 Other hyperaldosteronism
0.000 0.985 0.014
E26.1 Secondary hyperaldosteronism
0.000 0.985 0.014
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.985 0.015
F22 Persistent delusional disorders
0.014 0.985 0.000
F19.1 Harmful use
0.014 0.986 0.000
F17.0 Acute intoxication
0.014 0.986 0.000
E53.1 Pyridoxine deficiency
0.000 0.986 0.014
E53.0 Riboflavin deficiency
0.000 0.986 0.014
E22.8 Other hyperfunction of pituitary gland
0.000 0.986 0.014
M49.5 Collapsed vertebra in diseases classified elsewhere
0.000 0.986 0.014
F15.1 Harmful use
0.014 0.986 0.000
F19.2 Dependence syndrome
0.014 0.986 0.000
M46 Other inflammatory spondylopathies
0.000 0.986 0.014
F12.1 Harmful use
0.013 0.986 0.000
F22.0 Delusional disorder
0.013 0.986 0.000
F11.3 Withdrawal state
0.013 0.987 0.000
F19.3 Withdrawal state
0.013 0.987 0.000
Chapter V Mental and behavioural disorders
0.013 0.987 0.000
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.987 0.013
F17.9 Unspecified mental and behavioural disorder
0.013 0.987 0.000
F13 Mental and behavioural disorders due to use of sedatives or hypnotics
0.013 0.987 0.000
F60-F69 Disorders of adult personality and behaviour
0.013 0.987 0.000
F17.3 Withdrawal state
0.013 0.987 0.000
F18 Mental and behavioural disorders due to use of volatile solvents
0.013 0.987 0.000
F16 Mental and behavioural disorders due to use of hallucinogens
0.013 0.987 0.000
E23.7 Disorder of pituitary gland, unspecified
0.000 0.987 0.013
E20.8 Other hypoparathyroidism
0.000 0.987 0.012
E20.0 Idiopathic hypoparathyroidism
0.000 0.987 0.012
E23.0 Hypopituitarism
0.000 0.987 0.013
E22.1 Hyperprolactinaemia
0.000 0.987 0.012
E53.9 Vitamin B deficiency, unspecified
0.000 0.988 0.012
F14 Mental and behavioural disorders due to use of cocaine
0.012 0.988 0.000
F60.3 Emotionally unstable personality disorder
0.012 0.988 0.000
F12.5 Psychotic disorder
0.012 0.988 0.000
F12.0 Acute intoxication
0.012 0.988 0.000
F17.8 Other mental and behavioural disorders
0.012 0.988 0.000
F17.7 Residual and late-onset psychotic disorder
0.012 0.988 0.000
F17.6 Amnesic syndrome
0.012 0.988 0.000
F17.5 Psychotic disorder
0.012 0.988 0.000
F17.4 Withdrawal state with delirium
0.012 0.988 0.000
E78.5 Hyperlipidaemia, unspecified
0.000 0.988 0.012
F19.9 Unspecified mental and behavioural disorder
0.012 0.988 0.000
F19.8 Other mental and behavioural disorders
0.012 0.988 0.000
F19.7 Residual and late-onset psychotic disorder
0.012 0.988 0.000
F19.6 Amnesic syndrome
0.012 0.988 0.000
F19.5 Psychotic disorder
0.012 0.988 0.000
F19.4 Withdrawal state with delirium
0.012 0.988 0.000
F19.0 Acute intoxication
0.012 0.988 0.000
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere
0.000 0.988 0.012
K93.1 Megacolon in Chagas' disease
0.000 0.988 0.012
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands
0.000 0.988 0.012
F23 Acute and transient psychotic disorders
0.012 0.988 0.000
F60 Specific personality disorders
0.012 0.988 0.000
F11.9 Unspecified mental and behavioural disorder
0.012 0.988 0.000
F11.8 Other mental and behavioural disorders
0.012 0.988 0.000
F11.7 Residual and late-onset psychotic disorder
0.012 0.988 0.000
F11.6 Amnesic syndrome
0.012 0.988 0.000
F11.5 Psychotic disorder
0.012 0.988 0.000
F11.4 Withdrawal state with delirium
0.012 0.988 0.000
F11.0 Acute intoxication
0.012 0.988 0.000
F69 Unspecified disorder of adult personality and behaviour
0.012 0.988 0.000
E20.1 Pseudohypoparathyroidism
0.000 0.988 0.011
F11.1 Harmful use
0.012 0.988 0.000
F28 Other nonorganic psychotic disorders
0.012 0.988 0.000
F24 Induced delusional disorder
0.012 0.988 0.000
F21 Schizotypal disorder
0.012 0.988 0.000
M49.09 Tuberculosis of spine (Site unspecified)
0.000 0.988 0.011

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.